GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Health Italia SpA (MIL:HI) » Definitions » Peter Lynch Fair Value

Health Italia SpA (MIL:HI) Peter Lynch Fair Value : €150.41 (As of May. 11, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Health Italia SpA Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Health Italia SpA's PEG is 1. Health Italia SpA's 5-Year TTM EBITDA Growth Rate is 8.97. Health Italia SpA's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was €16.77. Therefore, the Peter Lynch Fair Value for today is €150.41.

As of today (2024-05-11), Health Italia SpA's share price is €125.50. Health Italia SpA's Peter Lynch fair value is €150.41. Therefore, Health Italia SpA's Price to Peter Lynch Fair Value Ratio for today is 0.83.


The historical rank and industry rank for Health Italia SpA's Peter Lynch Fair Value or its related term are showing as below:

MIL:HI' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.8   Med: 0.97   Max: 1.14
Current: 0.83


During the past 9 years, the highest Price to Peter Lynch Fair Value Ratio of Health Italia SpA was 1.14. The lowest was 0.80. And the median was 0.97.


MIL:HI's Price-to-Peter-Lynch-Fair-Value is ranked better than
77.78% of 9 companies
in the Healthcare Plans industry
Industry Median: 1.6 vs MIL:HI: 0.83

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Health Italia SpA Peter Lynch Fair Value Historical Data

The historical data trend for Health Italia SpA's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Health Italia SpA Peter Lynch Fair Value Chart

Health Italia SpA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Peter Lynch Fair Value
Get a 7-Day Free Trial Premium Member Only - 172.35 - - 150.41

Health Italia SpA Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 150.41

Competitive Comparison of Health Italia SpA's Peter Lynch Fair Value

For the Healthcare Plans subindustry, Health Italia SpA's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Health Italia SpA's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Health Italia SpA's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Health Italia SpA's Price-to-Peter-Lynch-Fair-Value falls into.



Health Italia SpA Peter Lynch Fair Value Calculation

Health Italia SpA's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 8.97 *16.768
=150.41

For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Health Italia SpA's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was €16.77.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Health Italia SpA  (MIL:HI) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 8.97 instead of 15 in this case.

Health Italia SpA's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=125.50/150.41
=0.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Health Italia SpA Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Health Italia SpA's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Health Italia SpA (MIL:HI) Business Description

Traded in Other Exchanges
Address
Via di Santa Cornelia, 9, Formello, ITA, 00060
Health Italia SpA is an Italy based company engaged in offering integrated healthcare services. It operates in the promotion of integrated and alternative healthcare solutions and provides administrative, liquidation, information technology and consulting services for health funds, health care funds and mutual-aid companies. In addition, the group is also active in the corporate welfare market and manages outsourced flexible benefit welfare plans.